| ESR1 ligand-binding domain mutations in hormone-resistant breast cancer W Toy, Y Shen, H Won, B Green, RA Sakr, M Will, Z Li, K Gala, S Fanning, ... Nature genetics 45 (12), 1439-1445, 2013 | 1110 | 2013 |
| Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) Tumor Pathology in … N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 689 | 2012 |
| Clinical management factors contribute to the decision for contralateral prophylactic mastectomy TA King, R Sakr, S Patil, I Gurevich, M Stempel, M Sampson, M Morrow Journal of Clinical Oncology 29 (16), 2158-2164, 2011 | 343 | 2011 |
| Progression from ductal carcinoma in situ to invasive breast cancer: revisited CF Cowell, B Weigelt, RA Sakr, CKY Ng, J Hicks, TA King, JS Reis-Filho Molecular oncology 7 (5), 859-869, 2013 | 323 | 2013 |
| Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ... Nature genetics 46 (11), 1166-1169, 2014 | 204 | 2014 |
| Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast CancerPI3K/AKT Activation in Trastuzumab Resistance S Chandarlapaty, RA Sakr, D Giri, S Patil, A Heguy, M Morrow, S Modi, ... Clinical Cancer Research 18 (24), 6784-6791, 2012 | 204 | 2012 |
| Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk TA King, M Pilewskie, S Muhsen, S Patil, SK Mautner, A Park, S Oskar, ... Journal of clinical oncology 33 (33), 3945, 2015 | 169 | 2015 |
| In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer M Janiszewska, L Liu, V Almendro, Y Kuang, C Paweletz, RA Sakr, ... Nature genetics 47 (10), 1212-1219, 2015 | 163 | 2015 |
| The genomic landscape of male breast cancers S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ... Clinical Cancer Research 22 (16), 4045-4056, 2016 | 141 | 2016 |
| Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of … AM Mulligan, FJ Couch, D Barrowdale, SM Domchek, D Eccles, ... Breast Cancer Research 13, 1-20, 2011 | 138 | 2011 |
| Genomic Complexity and AKT Dependence in Serous Ovarian CancerGenomics and AKT in Ovarian Cancer AJ Hanrahan, N Schultz, ML Westfal, RA Sakr, DD Giri, S Scarperi, ... Cancer discovery 2 (1), 56-67, 2012 | 122 | 2012 |
| Ductal carcinoma in situ: value of sentinel lymph node biopsy R Sakr, E Barranger, M Antoine, H Prugnolle, E Daraï, S Uzan Journal of surgical oncology 94 (5), 426-430, 2006 | 94 | 2006 |
| Protocol for PTEN expression by immunohistochemistry in formalin-fixed paraffin-embedded human breast carcinoma RA Sakr, V Barbashina, M Morrogh, S Chandarlapaty, VP Andrade, ... Applied immunohistochemistry & molecular morphology: AIMM/official …, 2010 | 73 | 2010 |
| Risk of breast cancer associated with papilloma R Sakr, R Rouzier, C Salem, M Antoine, J Chopier, E Darai, S Uzan European Journal of Surgical Oncology (EJSO) 34 (12), 1304-1308, 2008 | 73 | 2008 |
| Is there a role for routine screening MRI in women with LCIS? TA King, S Muhsen, S Patil, S Koslow, S Oskar, A Park, M Morrogh, ... Breast cancer research and treatment 142, 445-453, 2013 | 60 | 2013 |
| Cadherin–catenin complex dissociation in lobular neoplasia of the breast M Morrogh, VP Andrade, D Giri, RA Sakr, W Paik, LX Qin, CD Arroyo, ... Breast cancer research and treatment 132, 641-652, 2012 | 59 | 2012 |
| Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations E Guerini‐Rocco, S Piscuoglio, CKY Ng, FC Geyer, MR De Filippo, ... The Journal of pathology 238 (5), 677-688, 2016 | 56 | 2016 |
| PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ—Implications for Progression to Invasive Breast CarcinomaPI3K Pathway in DCIS RA Sakr, B Weigelt, S Chandarlapaty, VP Andrade, E Guerini-Rocco, ... Clinical Cancer Research 20 (9), 2326-2337, 2014 | 54 | 2014 |
| Bi‐allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer RW Mutter, N Riaz, CKY Ng, R Delsite, S Piscuoglio, M Edelweiss, ... The Journal of pathology 242 (2), 165-177, 2017 | 50 | 2017 |
| The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ: risk factors for unsuspected invasive disease and for … R Sakr, C Bezu, I Raoust, M Antoine, F Ettore, J Darcourt, K Kerrou, ... International journal of clinical practice 62 (11), 1730-1735, 2008 | 49 | 2008 |
